Subcortical vascular versus amnestic mild cognitive impairment: comparison of cerebral glucose metabolism

Sang Won Seo1, Sang Soo Cho, Aram Park

  • 1Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Abstract

Insights

Subcortical vascular MCI (svMCI) shows distinct brain glucose metabolism patterns compared to amnestic MCI (aMCI). PET imaging reveals significant differences in hypometabolism, particularly in the thalamus, brainstem, and cerebellum for svMCI patients.

Area of Science:

  • Neuroimaging
  • Neurology
  • Metabolic Disorders

Background:

  • Mild cognitive impairment (MCI) research predominantly focuses on amnestic MCI (aMCI), a precursor to Alzheimer's disease (AD).
  • Subcortical vascular MCI (svMCI), a less-studied preclinical stage of vascular dementia, requires further investigation.
  • Understanding metabolic differences is crucial for accurate diagnosis and management of MCI subtypes.

Purpose of the Study:

  • To compare the overall glucose metabolism patterns between patients with svMCI and aMCI.
  • To identify distinct neuroimaging biomarkers for differentiating svMCI from aMCI.
  • To elucidate the underlying pathophysiology of svMCI using positron emission tomography (PET).

Main Methods:

  • 18F-fluorodeoxyglucose (FDG) PET imaging was used to assess regional glucose metabolism.
  • Voxel-wise analysis compared metabolic patterns in 18 svMCI patients, 25 aMCI patients, and 35 healthy controls.
  • Patients were matched for age, sex, education, and Mini-Mental State Examination (MMSE) scores.

Main Results:

  • aMCI patients exhibited hypometabolism in the parahippocampal gyri, posterior cingulate, and temporal/parietal/frontal lobes.
  • svMCI patients showed hypometabolism in the thalamus, insula, cingulate gyrus, basal ganglia, cerebellum, and brainstem.
  • Direct comparison revealed more severe hypometabolism in the thalamus, brainstem, and cerebellum in svMCI compared to aMCI.

Conclusions:

  • svMCI is neurobiologically distinct from aMCI, as evidenced by differing patterns of glucose hypometabolism.
  • These PET findings correlate with distinct neuropsychological profiles, aiding in clinical differentiation.
  • The study highlights the utility of FDG-PET in characterizing MCI subtypes and their underlying pathologies.